Printer Friendly
The Free Library
14,634,800 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

FDA to Present on Medical Device User Fee & Modernization Act at Upcoming OEM Event.


Business Editors & Medical Writers

MD&M West 2003

LOS ANGELES--(BUSINESS WIRE)--Jan. 14, 2003

In an attempt to expedite market approval of medical devices, President George W. Bush signed into law a bill establishing the assessment of user fees for medical device manufacturers. The new law, named the Medical Device User Fee & Modernization Act of 2002 (MDUFMA MDUFMA Medical Device User Fee and Modernization Act ), was developed to improve the FDA's ability to provide access to safe and effective medical devices. The user fees, paid by medical device makers seeking premarket approval, will help advance the device approval process, reduce time to market and allow consumers earlier access to new treatments and technologies. Furthermore, the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 has broadened its review process by allowing manufacturers to utilize third parties to conduct their FDA required inspections.

At the upcoming Medical Design & Manufacturing (MD&M) West conference, held at the Anaheim Convention Center Anaheim Convention Center is a major convention center in Anaheim, California. It is located across from the Disneyland Resort on Katella Avenue. Much of the Anaheim Convention Center has been renovated in recent years with state-of-the-art facilities. , February 19-21, manufacturers interested in learning how this bill will affect their companies are urged to attend a session lead by Federal Drug Administration representative William M. Sutton, consumer safety officer from the Center for Devices and Radiological Health The Center for Devices and Radiological Health (CDRH) is the branch of the United States Food and Drug Administration responsible for the premarket approval of all medical devices, as well as overseeing the manufacturing, performance and safety of these devices.  (CDRH CDRH Center for Devices and Radiological Health (US FDA) ).

"When the President signed the Medical Device User Fee and Modernization Act in October, he provided the FDA with important new responsibilities, resources, and challenges," said Sutton. "Our session at MD&M West will present an overview of MDUFMA, which includes a summary that is intended to describe three key provisions of the new law: 1) user fees for pre-market reviews; 2) establishment inspections by accredited accredited

recognition by an appropriate authority that the performance of a particular institution has satisfied a prestated set of criteria.


accredited herds
cattle herds which have achieved a low level of reactors to, e.g.
 third parties; and 3) new regulatory requirement for reprocessed single use devices."

In addition, Larry Spears, Director of Office of Compliance (OC) will co-present the session providing an update on enforcement activity and an overview on CDRH points of focus for 2003.

The four-day, multi-track conference program will cover a variety of sessions such as Fundamentals of Medical Plastics Selection and Evaluation, Practical Software Validation, and Medical Packaging Design. In addition, manufacturers will be attracted to the wall-to-wall design, manufacturing, and packaging event featuring five events: MD&M West, PLASTEC PLASTEC Plastics Technical Evaluation Center  West Pavilion, WestPack, Pacific Design & Manufacturing and Electronics West.

For more information about the MD&M West conference program and exposition, please visit the Web site at www.mdmwest.com. Produced and managed by CANON COMMUNICATIONS LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
, the Anaheim event is part of the company's worldwide family of trade shows. Information on all of CANON'S shows can be found at www.canontradeshows.com or by calling 310/445-4200.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 14, 2003
Words:407
Previous Article:Emerson Radio Announces Letter of Intent Finalization With Sanlian Group, One of the Largest Retailers of Electronic Products in China.
Next Article:AvantGo Receives Notice of Allowance for Third Mobile Technology Patent.



Related Articles
The FDA Follies.
Medical products makers irked by approvals delays. (Special Report: Health Care)
FDA Public Health Advisory: Need for Caution when Using Vacuum Assisted Delivery Devices.
Manufacturers may promote off-label uses for drugs.
Consumer alert files suit on Pediatric rule.(Brief Article)
An overview of drug development in the United States and current challenges.(Featured CME Topic)
CA hails court decision on Pediatric Rule.
FDA advisory hearing on new-fill (Sculptra), March 25, 2004 in Gaithersburg, Maryland.(Brief Article)
The risky business of off-label use: off-label use of drugs and devices is an accepted part of modern medical practice. When harm results, lawyers...
What's wrong with the FDA? Either too fast or too slow, the agency can't find the right balance.(POLICY)(Food and Drug Administration)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles